KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 139 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $93,950 | +50959.8% | 156,584 | +80613.4% | 0.00% | – |
| Q4 2023 | $184 | -99.9% | 194 | -99.1% | 0.00% | -100.0% |
| Q4 2022 | $154,528 | -7.5% | 21,950 | +118.3% | 0.00% | 0.0% |
| Q1 2022 | $167,000 | +119.7% | 10,053 | -36.0% | 0.00% | 0.0% |
| Q3 2020 | $76,000 | – | 15,699 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
| Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
| Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
| Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
| CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
| Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
| Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |